BEDFORD, Mass.--(BUSINESS WIRE)--SpectraWAVE, Inc. today announced a $13.2 million Series A-2 financing to support completion of product development and regulatory filing for its flagship ...

BEDFORD, Mass.--(BUSINESS WIRE)--SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for patients with coronary artery disease (CAD), today announced the ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Philips has agreed to acquire SpectraWAVE, a firm making ...

LIÈGE, Belgium & BEDFORD, Mass., November 18, 2025--(BUSINESS WIRE)--CryoTherapeutics, a medical device company developing minimally invasive localized cryotherapy for the treatment of coronary artery ...

Philips has claimed the cardiac artificial intelligence developer SpectraWAVE in a bid to expand the capabilities of its real-time imaging platform with rapid scans of the heart’s arteries. “We are ...

-- Interventional cardiologist with extensive clinical study experience and expertise in intravascular imaging, physiology, and complex PCI to guide worldwide clinical strategy -- SpectraWAVE, Inc., a ...

SpectraWAVE, the Massachusetts startup company whose technology combines two optical imaging techniques to aid treatment of coronary artery disease (CAD), has raised $50 million in a new round of ...

SpectraWAVE has raised $50 million to support its approach to imaging the insides of clogged, plaque-filled blood vessels. The Massachusetts-based company combines optical coherence tomography and ...

Acquisition of SpectraWAVE’s next-generation technologies including HyperVueTM Imaging System with Enhanced Vascular Imaging for comprehensive, rapid, and AI-supported imaging inside the coronary ...